EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarfield, A M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Clarfield, A M.
Evidence-Based Medicine 2001; 6:183
© 2001 Evidence-Based Medicine

Review: pharmacological and non-pharmacological interventions improve outcomes in patients with dementia and for their caregivers

Doody RS, Stevens JC, Beck C, et al.Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology 2001 May 8;56:1154–66[Abstract/Free Full Text]

QUESTION: Do pharmacotherapy, educational, or other non-pharmacological interventions improve outcomes in patients with dementia or for their caregivers?

Data sources
Studies were identified by searching Medline, EMBASE/Excerpta Medica, CINAHL, Current Contents, Psychological Abstracts, PsycINFO, and the Cochrane databases with terms that include Alzheimer's disease (AD), vascular or multi-infarct dementia, dementia with associated parkinsonian disorder, progressive supranuclear palsy, frontotemporal dementia, and senile dementia. Additional terms used were question specific. Bibliographies of relevant papers were also reviewed.

Study selection
Studies were selected if they were randomised controlled trials published in any language or other types of studies published in English with > 20 participants.

Data extraction
Data were extracted on study quality, participant characteristics, interventions, outcome measures, and results.

Main results
380 articles met the selection criteria. Several studies comparing cholinesterase inhibitors (eg, tacrine, donepezil, tartrate, and galantamine) with placebo showed that these drugs were more effective than placebo for improving cognitive outcomes in a subgroup of patients with mild-to-moderate AD. Studies of cholinergic precursors (eg, lecithin) and muscarinic agonists (eg, xanomeline) for the treatment of AD . . . [Full text of this article]

A Mark Clarfield, MD

Soroka Hospital Centre and Ben Gurion University of the Negev Beersheva, Israel







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd.